$0.144
+0.000 (+0.21%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Silexion Therapeutics Corp (SLXN) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting SLXN is Sell.
Silexion Therapeutics Corp (SLXN) 20-Day simple moving average is 0.16, while Silexion Therapeutics Corp (SLXN) share price is $—, making it Sell.
Silexion Therapeutics Corp (SLXN) 60-Day simple moving average is 0.28, while Silexion Therapeutics Corp (SLXN) share price is $—, making it Sell.
Technical Analysis for SLXN
AI Technical SLXNAs of 2026-11-07, the technical board for Silexion Therapeutics Corp (SLXN) reads sell: 3 indicators are flashing buy, 8 are indicating sell, and 2 are neutral. Price at $0.14 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 29.448, MACD stands at -0.0468 (Sell), Stochastic %K stands at 8.783 (Buy), Stochastic %D stands at 13.33 and CCI stands at -241.737 (Buy).
SLXN trades below the 60-day SMA (0.28) and below the 200-day SMA (6.03). Immediate resistance sits at Classic R1 0.18, then R2 0.21. Support sits at Classic S1 0.11, then S2 0.08.
Silexion Therapeutics Corp (SLXN) Support & Resistance Level
Silexion Therapeutics Corp (SLXN) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 29.448 |
| STOCHk_14_3_3 | 8.783 |
| STOCHd_14_3_3 | 13.330 |
| CCI_20 | -241.737 |
| AO_5_34 | -0.060 |
| MOM_10 | -0.054 |
| MACD_12_26_9 | -0.047 |
Silexion Therapeutics Corp (SLXN) Relative Strength Index (RSI_14) is 29.448, creating a Buy signal.
Silexion Therapeutics Corp (SLXN) Stochastic %K is 8.783, creating a Buy signal.
Silexion Therapeutics Corp (SLXN) Stochastic %D is 13.330, creating a Buy signal.
Silexion Therapeutics Corp (SLXN) CCI_20 is -241.737, creating a Buy signal.
Silexion Therapeutics Corp (SLXN) Awesome Oscillator (AO) is -0.060, creating a Sell signal.
Silexion Therapeutics Corp (SLXN) Momentum (MOM) is -0.054, creating a Sell signal.
Silexion Therapeutics Corp (SLXN) Moving Average Convergence Divergence (MACD) is -0.047, creating a Sell signal.
Silexion Therapeutics Corp (SLXN) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.143 | Buy |
| MA_10 | 0.147 | Sell |
| MA_20 | 0.158 | Sell |
| MA_60 | 0.279 | Sell |
| MA_200 | 6.025 | Sell |
| MA_250 | 9.753 | Sell |
Silexion Therapeutics Corp (SLXN) 5-Day simple moving average is 0.143, while Silexion Therapeutics Corp (SLXN) share price is $, making it a Buy.
Silexion Therapeutics Corp (SLXN) 10-Day simple moving average is 0.147, while Silexion Therapeutics Corp (SLXN) share price is $, making it a Sell.
Silexion Therapeutics Corp (SLXN) 20-Day simple moving average is 0.158, while Silexion Therapeutics Corp (SLXN) share price is $, making it a Sell.
Silexion Therapeutics Corp (SLXN) 60-Day simple moving average is 0.279, while Silexion Therapeutics Corp (SLXN) share price is $, making it a Sell.
Silexion Therapeutics Corp (SLXN) 200-Day simple moving average is 6.025, while Silexion Therapeutics Corp (SLXN) share price is $, making it a Sell.
Silexion Therapeutics Corp (SLXN) 250-Day simple moving average is 9.753, while Silexion Therapeutics Corp (SLXN) share price is $, making it a Sell.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.